Vaccinations have provided significant protection for the public against infectious diseases. However, there was a modest decrease in support in 2023 nationwide for vaccine…
In Philadelphia last week, researchers from leading universities, working professionals at pharmaceutical and biotechnology companies, Alzheimer’s advocates, and medical professionals gathered at the annual…
As people age, cognitive function tends to decline. In some people, this process happens faster than others. Mounting research points to the idea that…
Cassava Sciences’ experimental Alzheimer’s drug simufilam is currently in clinical trials. Meanwhile, the company is experiencing a major shake-up. Its CEO and lead neuroscientist…
A new drug for Alzheimer’s was just this month approved by the FDA for use in the United States, in people in the earliest…
In the 1840s, near Utah’s Great Salt Lake, a little piece of DNA went haywire. This genetic malfunction gave rise to a rare disorder…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. An Alzheimer’s diagnosis is often talked about…
Alzheimer’s disease affects millions of people worldwide, and as the world’s population ages, that number is going up. But, the exact cause of Alzheimer’s…
As of a landmark policy change in October 2023, Medicare now covers PET scans to look for Alzheimer’s biomarker beta-amyloid in the brain for…
Today in the United Kingdom, people who are concerned they may be showing the early signs of Alzheimer’s disease or another form of dementia…
The science behind Alzheimer’s is constantly developing, but its cause remains elusive and the disease is frequently misdiagnosed. A 2017 study at a hospital…
A new generation of Alzheimer’s treatments — groundbreaking, disease-modifying monoclonal antibody drugs — is on the rise, and two so far have hit the…
Some 65 percent of adults over the age of 60 live with hearing loss — and mounting research shows it is a controllable risk…
As Dr. Jeff Chen MD, MBA recalled in a recent talk at the 2023 TED Conference in Vancouver, BC, when he was a medical…
Today, more than 55 million people are living with Alzheimer’s disease globally. In the U.S., one in 10 people over the age of 65,…